Bone scan boost: could Whole-Body SPECT sharpen radiation targeting for metastatic prostate cancer?
NCT ID NCT06439784
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This trial explores whether a whole-body bone scan (SPECT/CT) taken in the treatment position can help doctors plan stereotactic radiotherapy more precisely for prostate cancer that has spread to the bones. Thirty patients will receive the scan in addition to standard imaging, and researchers will compare radiation plans created with and without the SPECT images. The goal is to see if the SPECT-based plans are equivalent or better, potentially allowing for more accurate targeting of tumors.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- whole-body SPECT/CT imaging using VERITON-CT CZT camera
- What this could lead to
- If SPECT/CT proves equivalent or superior to standard imaging, it could enable more precise radiotherapy planning and potentially better outcomes for prostate cancer patients with bone metastases.
- What could go wrong
- This is a small, early feasibility study with only 30 participants. The imaging technique may not translate into meaningful clinical benefits, and the results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER WITH BONE METASTASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Henri Becquerel
Rouen, 76038, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI could make radiation therapy more precise by tracking tumors in real time
- Could a few weeks of radiation be enough for recurrent prostate cancer?
- 10,000 men join quest to decode prostate cancer through scans
- New cancer drug trial halted early – what we know
- Double radiation attack on prostate cancer shows promise
- New scan could spot hidden prostate cancer